A

SELL

Agilent Technologies, Inc.

Healthcare · Rank #155 · Analyzed Jul 13, 2026

$134.29

Current Price

$75.47

Intrinsic Value

-43.8%

Upside/Downside

3.5/10

Score

3.5/5

Quality

Analysis Summary

Valuation Consensus0/2 methods agree

Quality Score3.5/5.0

Framework RatingSELL

Price vs Intrinsic ValueOvervalued by 43.8%

Fair Value Range

Low$37.42

Base (IV)$75.47

High$103.39

Entry Points

Conservative$26.20

Moderate$37.42

Aggressive$52.83

Quality & Moat Breakdown

Return on Equity21.3% → 1.0/1.0

Debt LevelD/E 50 → 0.5/1.0

Revenue QualityGrowth 11.1%, margin Δ-8.6% +recovery → 1.0/1.0

Moat Strength2.0/5 → 0/1.0

Profit Margins19.6% → 1.0/1.0

Methodology

This analysis uses a unified valuation framework combining three methods, Discounted Cash Flow (3-scenario), Earnings Power Value, and Asset Valuation, with a quality scoring overlay. A stock needs 2/3 valuation methods to agree and a quality score ≥ 3.5/5 for a BUY rating.

Learn how this framework works →

This is a personal analysis tool, not financial advice. Do your own research before making investment decisions.